203 related articles for article (PubMed ID: 15485669)
1. Equine papillomavirus type 1: complete nucleotide sequence and characterization of recombinant virus-like particles composed of the EcPV-1 L1 major capsid protein.
Ghim SJ; Rector A; Delius H; Sundberg JP; Jenson AB; Van Ranst M
Biochem Biophys Res Commun; 2004 Nov; 324(3):1108-15. PubMed ID: 15485669
[TBL] [Abstract][Full Text] [Related]
2. Role of conformational epitopes expressed by human papillomavirus major capsid proteins in the serologic detection of infection and prophylactic vaccination.
Hines JF; Ghim SJ; Christensen ND; Kreider JW; Barnes WA; Schlegel R; Jenson AB
Gynecol Oncol; 1994 Oct; 55(1):13-20. PubMed ID: 7525426
[TBL] [Abstract][Full Text] [Related]
3. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
[TBL] [Abstract][Full Text] [Related]
4. Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae.
Cook JC; Joyce JG; George HA; Schultz LD; Hurni WM; Jansen KU; Hepler RW; Ip C; Lowe RS; Keller PM; Lehman ED
Protein Expr Purif; 1999 Dec; 17(3):477-84. PubMed ID: 10600468
[TBL] [Abstract][Full Text] [Related]
5. Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33.
Roth SD; Sapp M; Streeck RE; Selinka HC
Virol J; 2006 Oct; 3():83. PubMed ID: 17014700
[TBL] [Abstract][Full Text] [Related]
6. Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes.
Liu WJ; Liu XS; Zhao KN; Leggatt GR; Frazer IH
Virology; 2000 Aug; 273(2):374-82. PubMed ID: 10915608
[TBL] [Abstract][Full Text] [Related]
7. Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography.
Baek JO; Seo JW; Kim IH; Kim CH
Protein Expr Purif; 2011 Feb; 75(2):211-7. PubMed ID: 20716445
[TBL] [Abstract][Full Text] [Related]
8. Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions.
Liu WJ; Gissmann L; Sun XY; Kanjanahaluethai A; Müller M; Doorbar J; Zhou J
Virology; 1997 Jan; 227(2):474-83. PubMed ID: 9018146
[TBL] [Abstract][Full Text] [Related]
9. Papillomavirus virus-like particles as vehicles for the delivery of epitopes or genes.
Xu YF; Zhang YQ; Xu XM; Song GX
Arch Virol; 2006 Nov; 151(11):2133-48. PubMed ID: 16791442
[TBL] [Abstract][Full Text] [Related]
10. Virus-like particles and E1-E4 protein expressed from the human papillomavirus type 11 bicistronic E1-E4-L1 transcript.
Brown DR; Pratt L; Bryan JT; Fife KH; Jansen K
Virology; 1996 Aug; 222(1):43-50. PubMed ID: 8806486
[TBL] [Abstract][Full Text] [Related]
11. Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells.
Mossadegh N; Gissmann L; Müller M; Zentgraf H; Alonso A; Tomakidi P
Virology; 2004 Aug; 326(1):57-66. PubMed ID: 15262495
[TBL] [Abstract][Full Text] [Related]
12. HPV11 mutant virus-like particles elicit immune responses that neutralize virus and delineate a novel neutralizing domain.
Ludmerer SW; McClements WL; Wang XM; Ling JC; Jansen KU; Christensen ND
Virology; 2000 Jan; 266(2):237-45. PubMed ID: 10639310
[TBL] [Abstract][Full Text] [Related]
13. Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes.
Kondo K; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
J Med Virol; 2008 May; 80(5):841-6. PubMed ID: 18360909
[TBL] [Abstract][Full Text] [Related]
14. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
[TBL] [Abstract][Full Text] [Related]
15. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.
Christensen ND; Cladel NM; Reed CA; Budgeon LR; Embers ME; Skulsky DM; McClements WL; Ludmerer SW; Jansen KU
Virology; 2001 Dec; 291(2):324-34. PubMed ID: 11878901
[TBL] [Abstract][Full Text] [Related]
16. Cross-reactivity among sapovirus recombinant capsid proteins.
Hansman GS; Natori K; Oka T; Ogawa S; Tanaka K; Nagata N; Ushijima H; Takeda N; Katayama K
Arch Virol; 2005 Jan; 150(1):21-36. PubMed ID: 15449145
[TBL] [Abstract][Full Text] [Related]
17. Baculovirus expression of beak and feather disease virus (BFDV) capsid protein capable of self-assembly and haemagglutination.
Stewart ME; Bonne N; Shearer P; Khalesi B; Sharp M; Raidal S
J Virol Methods; 2007 May; 141(2):181-7. PubMed ID: 17218022
[TBL] [Abstract][Full Text] [Related]
18. Equus caballus papillomavirus-2 (EcPV-2): an infectious cause for equine genital cancer?
Scase T; Brandt S; Kainzbauer C; Sykora S; Bijmholt S; Hughes K; Sharpe S; Foote A
Equine Vet J; 2010 Nov; 42(8):738-45. PubMed ID: 21039805
[TBL] [Abstract][Full Text] [Related]
19. [Expression, purification and immunogenicity of human papillomavirus type 11 virus-like particles from Escherichia coli].
Yan C; Li S; Wang J; Wei M; Huang B; Zhuang Y; Li Z; Pan H; Zhang J; Xia N
Wei Sheng Wu Xue Bao; 2009 Nov; 49(11):1527-33. PubMed ID: 20112683
[TBL] [Abstract][Full Text] [Related]
20. Noninfectious virus-like particle antigen for detection of swine vesicular disease virus antibodies in pigs by enzyme-linked immunosorbent assay.
Ko YJ; Choi KS; Nah JJ; Paton DJ; Oem JK; Wilsden G; Kang SY; Jo NI; Lee JH; Kim JH; Lee HW; Park JM
Clin Diagn Lab Immunol; 2005 Aug; 12(8):922-9. PubMed ID: 16085909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
